Corteva, Inc. (CTVA)

NYSE · Materials · Agricultural Inputs
By Alex · Tickerpine
$75.53
-0.69 (-0.91%)
Price — last all time monthly, dividend-adjusted · hover for detail
Market Cap
$50.39B
P/E (TTM)
46.3
Forward P/E
18.3
EPS (TTM)
$1.63
ROE
4.26%
Profit Margin
5.66%
Revenue Growth
-1.20%
Dividend Yield
0.94%
Beta
0.57
52W High
$90.97
52W Low
$60.53
Analyst Target
$92.40

CTVA stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$92.40
Implied upside
+22.3%

Wall Street analysts covering Corteva, Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $92.40 — +22.3% versus the last price of $75.53. Targets reflect analyst opinion, not a guarantee.

What would an investment in CTVA be worth today?
Run CTVA through our free historical return calculator.
Calculate CTVA returns →

CTVA historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +2.8% +2.8% $1,028
3 years +54.1% +15.5% $1,541
5 years +80.8% +12.6% $1,808
Since 2019 +206% +16.7% $3,059

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in CTVA.

CTVA annual returns by year

2026 YTD +13.2%
2025 +18.9%
2024 +20.2%
2023 -17.5%
2022 +25.6%
2021 +23.6%
2020 +33.5%

Congress trading in CTVA

7 members of Congress have disclosed trading CTVA — 2 purchases and 6 sales worth an estimated $104,500. Most recent disclosure: Sep 4, 2024.

See who in Congress traded CTVA →

About Corteva, Inc.

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. The company was founded in 1802 and is headquartered in Indianapolis, Indiana.

Company website ↗

CTVA Key Statistics

Previous Close$76.22P/E Ratio46.3
Market Cap$50.39BPEG Ratio1.23
Revenue (TTM)$17.81BROE4.26%
Gross Margin49.54%ROA4.55%
Debt / Equity19.2Employees21,500

CTVA in plain English

CTVA stock: frequently asked questions

What is Corteva, Inc.'s stock price today?

Corteva, Inc. (CTVA) last traded at $75.53 on the NYSE. Over the past 52 weeks the stock has traded between $60.53 and $90.97.

Is CTVA stock a buy or a sell?

Wall Street analysts' consensus rating on CTVA is "Buy", with an average 12-month price target of $92.40 — about +22.3% versus the current price of $75.53. Analyst targets are opinions, not guarantees; always do your own research.

Does CTVA pay a dividend?

Yes. Corteva, Inc. currently pays a dividend yielding about 0.94% per year at today's share price.

What is CTVA's P/E ratio?

CTVA trades at a trailing price-to-earnings ratio of 46.3, and 18.3 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade CTVA stock?

Yes — 7 members of Congress have disclosed trades in CTVA under the STOCK Act, totaling 2 purchases and 6 sales worth an estimated $104,500.

What is Corteva, Inc.'s ticker symbol?

Corteva, Inc. trades under the ticker symbol CTVA on the NYSE.

Compare CTVA with peers

CTVA vs LINLinde plc $479.43 CTVA vs NEMNewmont Corporation $117.84 CTVA vs FCXFreeport-McMoRan, Inc. $69.22 CTVA vs SHWThe Sherwin-Williams Company $360.20 CTVA vs ECLEcolab Inc. $278.43

Data last refreshed from public sources. Figures may be delayed. Not investment advice.